Filing Details
- Accession Number:
- 0000886163-16-000158
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-17 19:56:53
- Reporting Period:
- 2016-03-17
- Filing Date:
- 2016-03-17
- Accepted Time:
- 2016-03-17 19:56:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1237556 | W Matthew Foehr | 11119 North Torrey Pines Road, Suite 200 La Jolla CA 92037 | President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-03-17 | 6,400 | $9.97 | 83,062 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-03-17 | 6,400 | $96.70 | 76,662 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2016-03-17 | 2,250 | $9.97 | 78,912 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-03-17 | 6,400 | $0.00 | 6,400 | $9.97 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-03-17 | 2,250 | $0.00 | 2,250 | $9.97 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
85,610 | 2021-04-18 | No | 4 | M | Direct | |
83,360 | 2021-04-18 | No | 4 | M | Direct |
Footnotes
- Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 04/18/11.